Skip to main content
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
Published Web Location
http://europepmc.org/articles/PMC4297452?pdf=renderNo data is associated with this publication.
Abstract
TP53 mutations confer subgroup specific poor survival for children with medulloblastoma. We hypothesized that WNT activation which is associated with improved survival for such children abrogates TP53 related radioresistance and can be used to sensitize TP
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.